drugset / Trial / NCT02502669
Finasteride Treatment of Severe Nodulocystic Acne
RandomizedParallel-groupTriple-blindTreatment
Summary
Double-blind, randomized, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of once weekly, high dose oral finasteride compared to placebo for the treatment of severe nodulocystic acne in male subjects.
Timeline
- Start
- 2015-07
- Primary completion
- 2017-06-06
- Completion
- 2017-06-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Finasteride | Small molecule | 23.5 mg | Oral |
| Comparator | Finasteride | Small molecule | 33.5 mg | Oral |